Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

Bribery ‘routine’ for pharma in China

August 13, 2013 Sales and Marketing BBC, China, GSK, Sanofi, bribery, drug reps

News

Hugh McCafferty joins Pharmafocus editorial team

August 12, 2013 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, pharmafile

Appointment

Funding boost for UK health research projects

August 12, 2013 Medical Communications, Research and Development, Sales and Marketing Lord Howe, NIHR, UK government, funding boost

News

Sanofi ‘co-operating’ with China bribery case

August 12, 2013 Medical Communications, Sales and Marketing China, Drug pricing, GSK, Sanofi, bribery

News

Sanaria’s malaria vaccine shows promise

August 9, 2013 Research and Development, Sales and Marketing PfSPZ, Vaccine, malaria, sanaria

Researchers in the US have announced promising results from a Phase I clinical trial of biotech firm Sanaria’s new malaria …
News

AllTrials campaign releases manifesto

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bad pharma, GSK, Goldacre, NICE, transparency

The UK clinical trial transparency initiative AllTrials has released its first detailed manifesto as it looks to ramp up pressure …
News

GSK banks on bioelectronics with new fund

August 9, 2013 Medical Communications, Research and Development, Sales and Marketing Bioelectronics, COPD, GSK, asthma, diabetes

GSK has established a $50 million venture capital fund to invest in the emerging field of bioelectronics. Described as one …
News

BMJ appoints US managing director

August 9, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMJ, Campbell

Medical journal BMJ has hired Glen Campbell from Elsevier to be its US managing director. Campbell joins BMJ on 2 …
Appointment

GSK seeks licence extensions

August 8, 2013 Sales and Marketing Cervarix, EMA, GSK, Votrient

GlaxoSmithKline is seeking to extend the licences of two of its brands, Cervarix and Votrient, in a bid to extend …
News

Novartis recognised for efforts in cancer

August 8, 2013 Medical Communications, Sales and Marketing Bush, CEO, Cancer, Novartis

Novartis is the first company to earn a global CEO Cancer Gold Standard accreditation by the non-profit organisation CEO Roundtable …
News

Late-stage failure for Afinitor

August 8, 2013 Research and Development, Sales and Marketing Afinitor, Cancer, Novartis, liver

Novartis’ oncology programme has received a blow with the news that Afinitor has failed to help patients live longer in …
News

New junior planner at PAN

August 8, 2013 Medical Communications, Sales and Marketing Pan, comms, doshi

Parrus Doshi has joined creative comms agency PAN from Langland Advertising as junior planner. Doshi was an account manager at …
Appointment

Merck KGaA declines in Q2

August 7, 2013 Sales and Marketing Erbitux, Merck KGaA, Q2, Serono

Sales of cancer drug Erbitux dropped as Merck Serono’s revenues for the second quarter of 2013 dipped year-on-year, the firm …
News

Report: ‘Improve NHS safety’

August 7, 2013 Sales and Marketing Cameron, Hunt, Mid Staffs, NHS

Patient safety is the key to future NHS success, according to a new review commissioned after the final report of …
News

Eylea trial boost in DME

August 7, 2013 Research and Development, Sales and Marketing Bayer, DME, Eylea, regenenron

The rival treatment to Novartis’ Lucentis has posted encouraging new study results in patients with diabetic macular oedema (DME). In …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026